Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, May 02, 2025 (GLOBE NEWSWIRE) -- The "North America Athletic Wear Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's...
-
Best Anti-Snoring Devices: Stop Snoring Immediately. New Report Reveals Which Devices Actually Work.
New York, May 02, 2025 (GLOBE NEWSWIRE) -- WhatBest, a trusted resource for product research and rankings, has officially released its list of the best anti-snoring devices, spotlighting three...
-
Little Tandem’s Flagship Product The Frame Reaches Hundreds of U.S. Families Within Months of Launch
Little Tandem, a U.S. children's furniture company founded in 2024, reports strong adoption of The Frame, its flagship product designed to support children's independence and emotional well-being. The...
-
Austin, May 01, 2025 (GLOBE NEWSWIRE) -- The Hydroxyapatite Market Size was valued at USD 2.45 Billion in 2023 and is expected to reach USD 4.45 Billion by 2032, growing at a CAGR of 6.85% over the...
-
Neurogen Announces Partnership with NeuroX, a subsidiary of American TelePhysicians
-
CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases,...
-
Panel to Discuss Current Challenges Encountered by Patients with HCV, Results from Atea’s Phase 2 Study of the Regimen of Bemnifosbuvir and Ruzasvir, and What a New Optimized HCV Therapy Could Provide...
-
ZUG, Switzerland, May 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and...
-
ZUG, Switzerland, May 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and...
-
Partnership Development and Risk Management Expert Michelle Young Joins the Friendly Team